Orlandini C - Search Results

1

Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.

Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G. Ricci S, et al. Among authors: orlandini c. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1023-30. doi: 10.1007/s00259-006-0343-8. Epub 2007 Jan 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17242920

2

Safety and antitumor efficacy of (153)Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer.

Borsò E, Boni G, Pastina I, Lorenzoni A, Cianci C, Federici F, Mazzarri S, Orlandini C, Francesca F, Selli C, Ricci S, Rubello D, Mariani G. Borsò E, et al. Among authors: orlandini c. Nucl Med Commun. 2014 Jan;35(1):88-94. doi: 10.1097/MNM.0000000000000023. Nucl Med Commun. 2014. PMID: 24157942

3

Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.

Ricci S, Galli L, Chioni A, Iannopollo M, Antonuzzo A, Francesca F, Vocaturo V, Selli C, Orlandini C, Conte P. Ricci S, et al. Among authors: orlandini c. Cancer. 2002 Oct 1;95(7):1444-50. doi: 10.1002/cncr.10860. Cancer. 2002. PMID: 12237912 Free article. Clinical Trial.

4

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.

Pastina I, Giovannetti E, Chioni A, Sissung TM, Crea F, Orlandini C, Price DK, Cianci C, Figg WD, Ricci S, Danesi R. Pastina I, et al. Among authors: orlandini c. BMC Cancer. 2010 Sep 27;10:511. doi: 10.1186/1471-2407-10-511. BMC Cancer. 2010. PMID: 20875115 Free PMC article.

5

5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.

Di Paolo A, Lencioni M, Amatori F, Di Donato S, Bocci G, Orlandini C, Lastella M, Federici F, Iannopollo M, Falcone A, Ricci S, Del Tacca M, Danesi R. Di Paolo A, et al. Among authors: orlandini c. Clin Cancer Res. 2008 May 1;14(9):2749-55. doi: 10.1158/1078-0432.CCR-07-1529. Clin Cancer Res. 2008. PMID: 18451241 Free article.

6

Radioguided occult lesion localization of cervical recurrences from differentiated thyroid cancer: technical feasibility and clinical results.

Borsò E, Grosso M, Boni G, Manca G, Bianchi P, Puccini M, Arganini M, Cabria M, Piccardo A, Arlandini A, Orlandini C, Mariani G. Borsò E, et al. Among authors: orlandini c. Q J Nucl Med Mol Imaging. 2013 Dec;57(4):401-11. Q J Nucl Med Mol Imaging. 2013. PMID: 24322795 Clinical Trial.

7

Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.

Gennari A, Guarneri V, Landucci E, Orlandini C, Rondini M, Salvadori B, Ricci S, Conte PF. Gennari A, et al. Among authors: orlandini c. Clin Breast Cancer. 2002 Dec;3(5):346-52. doi: 10.3816/CBC.2002.n.038. Clin Breast Cancer. 2002. PMID: 12533265 Clinical Trial.

8

Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors.

Ricci S, Antonuzzo A, Galli L, Orlandini C, Ferdeghini M, Boni G, Roncella M, Mosca F, Conte PF. Ricci S, et al. Among authors: orlandini c. Am J Clin Oncol. 2000 Aug;23(4):412-5. doi: 10.1097/00000421-200008000-00020. Am J Clin Oncol. 2000. PMID: 10955874 Clinical Trial.

9

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.

Gennari A, Bruzzi P, Orlandini C, Salvadori B, Donati S, Landucci E, Guarneri V, Rondini M, Ricci S, Conte P. Gennari A, et al. Among authors: orlandini c. Br J Cancer. 2004 Mar 8;90(5):962-7. doi: 10.1038/sj.bjc.6601634. Br J Cancer. 2004. PMID: 14997190 Free PMC article.

10

Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.

Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, Zucchi V, Pasqualetti F, Mariani G. Manca G, et al. Among authors: orlandini c. J Nucl Med. 2008 Nov;49(11):1769-75. doi: 10.2967/jnumed.108.055350. Epub 2008 Oct 16. J Nucl Med. 2008. PMID: 18927334 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters